首页> 美国卫生研究院文献>other >How Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART?

【2h】

How Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART?

机译：基于依非韦伦的HAART的粘附失败和病毒学失败之间的机会之窗有多长时间？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeThe time between onset of nonadherence and onset of virological failure is unknown. However, this information is critical to the design, implementation, and testing of interventions aiming to forestall treatment failure.

机译：目的从不坚持到发生病毒学失败之间的时间是未知的。但是，此信息对于旨在预防治疗失败的干预措施的设计，实施和测试至关重要。

著录项

期刊名称 other
作者
Robert Gross; Warren B. Bilker; Hao Wang; Jennifer Chapman;
展开▼
作者单位

展开▼
年(卷),期 -1(9),3
年度 -1
页码 202–206
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
adherence antiretroviral therapy HIV virologic failure;

机译：依从性;抗逆转录病毒疗法;HIV;病毒学衰竭;

相似文献

外文文献
中文文献
专利

1. How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? [J] . Gross R, Bilker WB, Wang H, HIV clinical trials . 2008 ,第3期

机译：基于依非韦伦的HAART在依从性失败和病毒性失败之间的机会之窗是多长时间？
2. Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients [J] . International Journal of STD & AIDS . 2010 ,第3期

机译：从蛋白酶抑制剂转变为基于依非韦伦的抗逆转录病毒疗法可改善被病毒抑制患者的生活质量，治疗满意度和依从性，且病毒失败率低
3. Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients. [J] . Campo RE, Cohen C, Grimm K, International journal of STD & AIDS . 2010 ,第3期

机译：从蛋白酶抑制剂转变为基于依非韦伦的抗逆转录病毒疗法可以改善生活质量，治疗满意度和依从性，并且在受到病毒感染的患者中病毒感染率较低。
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Adherence to practice guidelines and heart failure patient outcomes before and after implementation of the HEARTFELT (HEART Failure Effectiveness and Leadership Team) intervention. [D] . Dykes, Patricia C. 2004

机译：在实施HEARTFELT（心力衰竭有效性和领导力团队）干预措施前后，都要遵守实践准则和心力衰竭患者的预后。
6. Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore India [O] . Maria L. Ekstrand, Anita Shet, Sara Chandy, -1

机译：印度班加罗尔对一线高活性抗逆转录病毒疗法（HAART）的病毒学失败和耐药突变引起的次优依从性
7. How Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART? [O] . Robert Gross, Warren B. Bilker, Hao Wang, 2008

机译：基于Efavirenz的HAART上的粘附失败和病毒学衰竭之间的机会窗口有多长？

How Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART?

摘要

著录项

相似文献

相关主题

期刊订阅